Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mockenhaupt

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|October 22, 2011
Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literatureM Ziemer, S H Kardaun, Y Liss, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 4, 1999
[Linear IgA dermatosis in an adult with clinical signs of Stevens-Johnson syndrome]B Schneck, C Termeer, M Mockenhaupt, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 26, 2002
[Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome]J M Weiss, M Mockenhaupt, E Schöpf, et al.
Acta Dermato-Venereologica|May 1, 1997
The dermal type of erythema multiforme: a rare variant of Stevens-Johnson syndrome or cases of clinical misclassification?O Hering, M Mockenhaupt, B Rzany, et al.
Experimental Dermatology|October 1, 1995
Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysisA Dietrich, Y Kawakubo, B Rzany, et al.
The British Journal of Dermatology|July 1, 1996
Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysisB Rzany, O Hering, M Mockenhaupt, et al.
Pharmacoepidemiology and Drug Safety|October 2, 2009
An application of propensity score methods to estimate the treatment effect of corticosteroids in patients with severe cutaneous adverse reactionsP Sekula, A Caputo, A Dunant, et al.
AIDS (London, England)|October 2, 2001
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysisJ P Fagot, M Mockenhaupt, J N Bouwes-Bavinck, et al.
Journal of Clinical Epidemiology|July 1, 1996
Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registryB Rzany, M Mockenhaupt, S Baur, et al.
The British Journal of Dermatology|February 19, 2013
Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysisS Lipowicz, P Sekula, S Ingen-Housz-Oro, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|October 22, 2011
Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literatureM Ziemer, S H Kardaun, Y Liss, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 4, 1999
[Linear IgA dermatosis in an adult with clinical signs of Stevens-Johnson syndrome]B Schneck, C Termeer, M Mockenhaupt, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 26, 2002
[Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome]J M Weiss, M Mockenhaupt, E Schöpf, et al.
Acta Dermato-Venereologica|May 1, 1997
The dermal type of erythema multiforme: a rare variant of Stevens-Johnson syndrome or cases of clinical misclassification?O Hering, M Mockenhaupt, B Rzany, et al.
Experimental Dermatology|October 1, 1995
Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysisA Dietrich, Y Kawakubo, B Rzany, et al.
The British Journal of Dermatology|July 1, 1996
Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysisB Rzany, O Hering, M Mockenhaupt, et al.
Pharmacoepidemiology and Drug Safety|October 2, 2009
An application of propensity score methods to estimate the treatment effect of corticosteroids in patients with severe cutaneous adverse reactionsP Sekula, A Caputo, A Dunant, et al.
AIDS (London, England)|October 2, 2001
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysisJ P Fagot, M Mockenhaupt, J N Bouwes-Bavinck, et al.
Journal of Clinical Epidemiology|July 1, 1996
Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registryB Rzany, M Mockenhaupt, S Baur, et al.
The British Journal of Dermatology|February 19, 2013
Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysisS Lipowicz, P Sekula, S Ingen-Housz-Oro, et al.
Pageof 3